TYLER GARCIA: Open Payments
NPI 1316536501 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 36 payments from 16 companies in 2025. Trend: 2023 $445 · 2024 $786 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 8 | $141 |
| Amgen Inc. | 2 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $71 |
| Lilly USA, LLC | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| SANOFI-AVENTIS U.S. LLC | 2 | $65 |
| Boston Scientific Corporation | 1 | $58 |
| Abbott Laboratories | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
Products named: Repatha, Kerendia, TRELEGY ELLIPTA, TZIELD, ELIQUIS, ACCOLADE SR, PREVNAR 20, KISUNLA.
Industry payments across AZ — which companies pay providers there.
